The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk.10te% Regulatory News (SAN)

Share Price Information for Sant Uk.10te% (SAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 148.15
Bid: 146.30
Ask: 150.00
Change: 0.00 (0.00%)
Spread: 3.70 (2.529%)
Open: 148.15
High: 148.15
Low: 148.15
Prev. Close: 148.15
SAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement on the Outcome of 2018 BoE Stress Test

28 Nov 2018 17:44

RNS Number : 8278I
Santander UK Group Holdings PLC
28 November 2018
 

28 November 2018

 

SANTANDER UK GROUP HOLDINGS PLC

 

STATEMENT ON THE OUTCOME OF THE 2018 BANK OF ENGLAND STRESS TESTS

 

Santander UK notes the publication of the results of the 2018 stress tests conducted on seven major UK banks and building societies by the Bank of England.

 

As a result of the exercise, the Bank of England does not require Santander UK to undertake any actions.

 

Since the introduction of IFRS 9 in January 2018 the stress test results are published on an IFRS 9 transitional and non-transitional basis, over a five-year stress period to the end of 2022.

 

On an IFRS 9 transitional basis Santander UK's lowest post-stress CRD IV end-point common equity tier 1 ('CET 1') capital ratio was modelled to be 10.8% before management actions and 10.9% after allowed management actions.

 

On an IFRS 9 non-transitional basis Santander UK's lowest post-stress CRD IV end-point CET 1 capital ratio, was modelled to be 9.5% before management actions and 9.7% after allowed management actions.

 

These results are significantly in excess of the CET 1 hurdle rate established by the Bank of England of 7.5% on an IFRS 9 transitional basis, and 7.7% on an IFRS 9 non-transitional basis.

 

Santander UK reported a CET 1 capital ratio of 13.1% as at 30 September 2018.

 

For the third year in a row, Santander UK had the lowest stressed CET1 ratio impact of all participating firms, demonstrating our resilient balance sheet and prudent approach to risk.

 

The Bank of England's CET1 hurdle rate comprises the CRR Pillar 1 minimum of 4.5% together with a Pillar 2A CET1 requirement, an estimate of the applicable Systemic Risk Buffer and an adjustment to offset the pro-cyclical impacts of IFRS 9. Santander UK expects that a Pillar 2A requirement of 3.1% and Systemic Risk Buffer will be set in the first quarter of 2019.

 

On an IFRS 9 transitional basis Santander UK's lowest post-stress end-point leverage ratio, over a five-year stress period to the end of 2022, was modelled to be 3.9% both before and after management actions.

 

On an IFRS 9 non-transitional basis Santander UK's lowest post-stress end-point leverage ratio, over a five-year stress period to the end of 2022, was modelled to be 3.4% both before and after management actions.

 

These results are in excess of the leverage threshold established by the Bank of England of 3.26% on an IFRS 9 transitional and 3.25% on an IFRS 9 non-transitional basis. Santander UK reported a leverage ratio of 4.4% as at 30 September 2018, consistent with the ratio as at 31 December 2017. As at 30 September 2018 the leverage exposure was £279bn. 

Disclaimer

Santander UK Group Holdings plc and Banco Santander, S.A. both caution that this announcement may contain forward-looking statements. Such forward-looking statements are found in various places throughout this announcement. Words such as "believes", "anticipates", "expects", "intends", "aims" and "plans" and other similar expressions are intended to identify forward-looking statements, but they are not the exclusive means of identifying such statements. Forward-looking statements include, without limitation, statements concerning our future business development and economic performance. These forward-looking statements are based on management's current expectations, estimates and projections and both Santander UK Group Holdings plc and Banco Santander, S.A. caution that these statements are not guarantees of future performance. We also caution readers that a number of important factors could cause actual results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in such forward-looking statements. We have identified certain of these factors in the forward looking statements on page 259 of the Santander UK Group Holdings plc 2017 Annual Report and page 72 of the Santander UK Group Holdings plc 2018 Half Yearly Financial Report. Investors and others should carefully consider the foregoing factors and other uncertainties and events. Undue reliance should not be placed on forward-looking statements when making decisions with respect to Santander UK Group Holdings plc, Santander UK plc, Banco Santander, S.A. and/or their securities. Such forward-looking statements speak only as of the date on which they are made, and we do not undertake any obligation to update or revise any of them, whether as a result of new information, future events or otherwise.

Contacts

Bojana FlintHead of Investor Relations020 7756 6474

Andy Smith Head of Media Relations020 7756 4212

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCPGGBWGUPRGMR
Date   Source Headline
2nd Apr 20206:22 pmRNSResult of AGM
23rd Mar 20207:00 amRNSExpiration of Tender Offer
17th Mar 20207:30 amRNSBOARD CHANGE
16th Mar 20205:06 pmRNSArticle 8
16th Mar 20208:36 amRNS1160 ISE Delisting Announcement
10th Mar 20207:00 amRNSSANTANDER UK APPOINTS TONY PRESTEDGE AS DEPUTY CEO
9th Mar 20203:50 pmRNSSantander UK plc - Pricing Announcement
9th Mar 20203:37 pmRNSTender Offer - Pricing
9th Mar 20202:26 pmRNSEarly results cash tender offer
9th Mar 20201:26 pmRNSResult of Tender Offer
3rd Mar 20202:38 pmRNSPublication of Supplementary Prospectus
3rd Mar 20202:34 pmRNSPublication of Supplementary Prospectus
3rd Mar 20207:15 amRNSAnnual Financial Report
28th Feb 20201:24 pmRNSEuro Medium Term Note Programme - Final Terms
24th Feb 20205:23 pmRNSSantander UK plc announces cash tender offer
24th Feb 20205:22 pmRNSTender Offer
12th Feb 20204:55 pmRNSGlobal Bond Programme Final Terms - Series 76
12th Feb 20204:35 pmRNSGlobal Bond Programme Series 75 - Final terms
30th Jan 20201:56 pmRNSGlobal Bond Programme - Supplementary Prospectus
30th Jan 20208:30 amRNSSANTANDER UK GROUP HOLDINGS PLC - BOARD CHANGE
29th Jan 20201:21 pmRNSPublication of Supplementary Prospectus
20th Jan 20208:38 amRNS1158 Notice of Delisting - XS2063664275
15th Jan 20203:39 pmRNSGlobal Bond Programme - Final Terms - Series 74
13th Jan 20205:19 pmRNSNotice of Delisting - Covered Bonds
18th Dec 20194:29 pmRNSNotice of Delisting Covered Bonds (Date Amendment)
17th Dec 20192:33 pmRNSNotice of Delisting - Covered Bond Programme
16th Dec 20196:02 pmRNSSantander UK Pass 2019 Bank of England Stress Test
9th Dec 20193:12 pmRNSArticle 8
9th Dec 20199:49 amRNSNotice of Delisting - series 1155 XS2035095459
12th Nov 20192:28 pmRNSGlobal Covered Bond Programme - Final Terms
30th Oct 201912:31 pmRNSPublication of Supplementary Prospectus
15th Oct 201910:00 amRNSNotice of De-Listing
7th Oct 20195:21 pmRNSArticle 8
7th Oct 20198:32 amRNSNotice Of Delisting - 1151
11th Sep 201912:46 pmRNSAmendments to Global Covered Bond Swap Agreement
3rd Sep 201910:15 amRNSNotice re Holmes Master Trust Libor Linked Notes
15th Aug 20199:00 amRNSBoard Changes
12th Aug 20192:37 pmRNSArticle 8
9th Aug 20194:54 pmRNSNotice of Delisting - XS1970465974
9th Aug 20193:58 pmRNSPublication of Suppl.Prospcts
9th Aug 20193:50 pmRNSPublication of Suppl.Prospcts
9th Aug 20197:37 amRNSHalf-year Report
23rd Jul 20195:03 pmRNSPublication of Suppl.Prospcts
23rd Jul 20194:59 pmRNSPublication of Suppl.Prospcts
23rd Jul 20197:15 amRNSQuarterly Management Statement - 30 June 2019
10th Jul 20192:00 pmRNSDirectorate Change
1st Jul 20194:30 pmRNSPublication of a Prospectus
10th Jun 20194:08 pmRNSArticle 8
10th Jun 20193:38 pmRNS1144 ISE Delisting Announcement
14th May 20193:53 pmRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.